Johnson & Johnson MedTech said Monarch is its first robotic-assisted technology to receive regulatory approval in China.

Johnson & Johnson first shared details on the Ottava surgical robotic platform nearly three years ago, and now its sharing its plans to seek FDA approval.

ReWalk Robotics announced that the Centers for Medicare & Medicaid Services (CMS) finalized a rule benefitting its exoskeleton technology.

Levita Magnetics announced the world’s first commercial use for its MARS magnetic-assisted robotic surgery platform.

CMR Surgical announced today that it raised a funding round worth $165 million (£133 million) and hit a milestone with its surgical robot.

Virtual Incision announced that it added a $30 million extension to its previous $46 million Series C financing round.

The latest evolution of the Maestro System focuses on manufacturing scalability, together with increased capability and has simplified both usability and training.

Asensus Surgical announced its second-quarter financial results and shared an update on its Luna surgical robot platform.

Moon Surgical announced today that it raised $55.4 million and appointed a surgical robotics veteran as the chair of its board.

The Galaxy surgical robot features advanced imaging technologies that provide real-time location updates for potentially cancerous lesions.

Alphatec announced that it acquired all assets related to the REMI robotic navigation system from Fusion Robotics.

Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022.

Ronovo Surgical announced that it closed a new round of financing, bringing its total funds raised to more than $50 million since 2020.

New features from Asensus Surgical include 3D measurement, digital tagging and image enhancement.

Intuitive Surgical released preliminary Q4 results that included a revenue miss, but the company expects da Vinci surgical robot procedures to grow.

Siemens Healthineers acquired Corindus for $1.1 billion in 2019. Corindus develops the CorPath robot-assisted device for coronary and peripheral vascular procedures.

Titan Medical announced today that it plans to review and evaluate strategic alternatives to unlock shareholder value.

Through magnetic propulsion, the company’s Bionauts can navigate the human body and deliver drugs locally.

Surgical robotics company described share consolidation as the last option to regain compliance with Nasdaq’s $1 per share minimum bid price requirement and retain its listing.

Robotic microsurgery company Medical Microinstruments announced today that it raised $75 million in a Series B financing round.

The latest generation of the Ekso Bionics platform, the EksoNR previously received clearance for stroke and spinal cord rehabilitation in 2016, then acquired brain injury (ABI) in 2020

The Xact Ace system combines image-based procedure planning and real-time monitoring with hands-free precise robotic insertion and non-linear steering.